임신 중 hydroxycortisone succinate을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

hydroxycortisone succinate은 임신 중 안전한가요?

EU/ECHA substance information shows harmonised classification for reproductive toxicity (Repr. 1A H360 and Repr.2 H361) for hydrocortisone 21‑hemisuccinate (CAS 2203-97-6), so this meets the criterion for confirmed reproductive hazard (h=3). The mechanism is glucocorticoid action with demonstrated ability of systemic corticosteroids to affect fetal development/placenta (m=2). For typical topical cosmetic use, systemic absorption is low (e=1), so exposure from normal topical cosmetic use is expected to be low but not zero. (Sources: ECHA brief profile / C&L inventory; guidance on topical corticosteroids in pregnancy).

hydroxycortisone succinate은 모유 수유 중 안전한가요?

Because of the harmonised reproductive classification for the substance (see ECHA) and the known systemic effects of hydrocortisone, a conservative approach assigns h=3 for lactation context as well. Mechanistically, corticosteroids can distribute systemically and small amounts can appear in milk (m=2). For topical cosmetic application (not systemic therapy), milk exposure is generally low unless applied directly to the breast/nipple (e=1). (Sources: ECHA C&L brief profile; LactMed and NHS topical corticosteroid guidance).

hydroxycortisone succinate은 아기 피부에 안전한가요?

Harmonised classification (ECHA) indicates reproductive hazard (h=3) for the substance; that harmonised CMR classification applies as the primary hazard signal. Mechanism remains hydrocortisone (glucocorticoid) activity (m=2). Dermal exposure and systemic uptake from baby skin are higher than adult per surface‑area‑to‑weight and immature barrier — therefore exposure score is increased by +1 versus adult topical use (adult e=1 → infant e=2). There is no infant‑specific innocuousness data for cosmetic use of this specific derivative. (Sources: ECHA brief profile; EDF/dermatology and guideline reviews on topical corticosteroids/pregnancy and child skin).

VeriMom은 hydroxycortisone succinate을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 hydroxycortisone succinate을 20/100 (높은 위험)로 평가합니다.

임신 중 hydroxycortisone succinate 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.